Show All
What does GeneDx do?
GeneDx Holdings Corp. through its subsidiaries Sema4 OpCo, Inc., and GeneDx, LLC, provides genomics-related diagnostic and information services and pursues genomics medical research. GeneDx, LLC. is a patient-centric health information company and leader in delivering clinical genomic answers to an ever-increasing community of patients, families and healthcare providers. With more than 20 years of experience in diagnosing rare disorders and diseases, GeneDx, LLC. has pioneered panels, exome and whole genome sequencing and has developed a proprietary genomic interpretation and information services platform in support of healthcare partners and patients globally. We create, follow, and are informed by cutting-edge science and technology. With one of the most sophisticated datasets of genomic information, we are able to identify new disease-causing genes, advancing the field of medicine through the detection, discovery, and diagnosis of genetic diseases.
Where are GeneDx’s corporate headquarters?
GeneDx’s headquarters are located in Stamford, Connecticut.
On what stock exchange are GeneDx shares traded, and what is the ticker symbol?
GeneDx is listed on the Nasdaq stock exchange under the ticker "WGS". Public warrants will trade under the ticker symbol WGSWW.
When did GeneDx begin trading under "WGS"?
GeneDx began trading under WGS on January 10, 2023. The Company previously traded under SMFR, reflective of the company’s former name, Sema4 which went public via merger with CM Life Sciences (CMLF), a special purpose acquisition company (SPAC), on July 23, 2021.
What is GeneDx’s fiscal year end?
GeneDx’s fiscal year end is December 31.
Does GeneDx pay dividends?
We have never paid any cash dividends on our capital stock. We anticipate that we will retain earnings, if any, to support operations and to finance the growth and development of our business. In addition, the terms of the revolving credit facility with Silicon Valley Bank, or SVB, precludes us from paying cash dividends without the prior written consent of SVB. Therefore, we do not expect to pay cash dividends for the foreseeable future.
Does GeneDx have a direct stock purchase plan?
GeneDx does not currently have a direct stock purchase plan.
Where can I find the latest corporate news releases and financial reports?
Our latest press releases can be found here and financial reports can be found here.
How can I view documents GeneDx has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
SEC filings can be found here or directly from the SEC at
Who are the Company's independent registered public accountants?
GeneDx’s independent registered public accountants are Ernst & Young LLP.
Who is the Company's external legal counsel?
Fenwick & West LLP serves as our external legal counsel and can be reached at:

Ethan Skerry

Per B. Chilstrom

Fenwick & West LLP

902 Broadway New York, New York 10010

(212) 430-2600

Who is the Company’s transfer agent?
Our transfer agent is Continental Stock Transfer & Trust Company and can be reached at:
Telephone: 212.509.4000
Mail: 1 State Street, 30th Floor | New York, NY 10004-1561
Who are the members of GeneDx Board of Directors?
You can view our Board of Directors by visiting the Board of Directors section of our website here.
Who are the members of GeneDx management team?
You can view our management team by visiting the Management Team section of our website here.
How do I contact Investor Relations with a question or request?
You can contact Sema4 Investor Relations via email at .